HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Chronic non-specific colitis — Clinical Guidelines

Overview

Chronic non-specific colitis refers to persistent inflammation of the colon without a specific identifiable cause, often presenting with symptoms like abdominal pain, diarrhea, and rectal bleeding. It is commonly seen in elderly patients with multiple comorbidities 1 2.

Diagnosis

Clinical symptoms including chronic diarrhea, abdominal pain, and rectal bleeding

Endoscopic findings showing nonspecific colonic inflammation

Exclusion of infectious, inflammatory bowel disease, and neoplastic causes through stool studies, biopsies, and imaging 1

Management

First-line treatments: Dietary modifications and symptomatic management

Adjunctive therapies: Use of tranquilizers like diazepam, alprazolam, temazepam, and lorazepam for symptom control in elderly patients; efficacy noted with low adverse effects 1

Lifestyle modifications: Encourage physical activity to manage comorbidities associated with chronic non-specific colitis 5

Special Populations

Elderly: Increased risk of polypharmacy and associated complications; careful monitoring of medication use is crucial 2

Comorbidities: Patients with chronic non-communicable diseases (CNCDs) often require tailored management plans addressing multiple conditions 2 3

Key Recommendations

Monitor and manage polypharmacy in elderly patients with chronic non-specific colitis to prevent adverse effects and complications (Evidence: Moderate 2)

Consider the use of tranquilizers for symptom control in elderly patients, selecting from diazepam, alprazolam, temazepam, and lorazepam based on efficacy and safety profiles (Evidence: Strong 1)

Implement comprehensive geriatric assessments (CGA) to address multifaceted health needs and support requirements in older adults with chronic conditions (Evidence: Moderate 2)

Promote physical activity as part of the management plan to mitigate risks associated with sedentary lifestyles and comorbidities (Evidence: Moderate 5)

References

1 Li J, Li J, Cui Y, Li H, Hou X, Zhao F et al.. Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis. Acta pharmaceutica (Zagreb, Croatia) 2023. link 2 Vitorino LM, Lopes Mendes JH, de Souza Santos G, Oliveira C, José H, Sousa L. Prevalence of Polypharmacy of Older People in a Large Brazilian Urban Center and its Associated Factors. International journal of environmental research and public health 2023. link 3 Montgomery L, Misinde C, Komuhangi A, Kawooya AN, Agaba P, McShane CM et al.. Tackling the escalating burden of care in Uganda: a qualitative exploration of the challenges experienced by family carers of patients with chronic non-communicable diseases. BMC health services research 2023. link 4 Chong MF, Godfrey KM, Gluckman P, Tan KH, Shek LP, Meaney M et al.. Influences of the perinatal diet on maternal and child health: insights from the GUSTO study. The Proceedings of the Nutrition Society 2020. link 5 Blair SN, Sallis RE, Hutber A, Archer E. Exercise therapy - the public health message. Scandinavian journal of medicine & science in sports 2012. link

Chronic non-specific colitis